COPD International   Your Support Network

You can learn to control this disease instead of letting it control you!

 

Return To The Main Library         <<<<>>>>         Return To The HomePage

 
 

Safety Alert 
March 2003


Boehringer Ingelheim Roxane Laboratories Recalls Micardis Tablets 
(anti-hypertensive)

The Food and Drug Administration (FDA) released the following information.

PRODUCT
Micardis Tablets, (telmisartan) 20 mg, 28 tablets, 4 blister cards of 7
tablets each, Rx only, NDC #00597-0039-28. Recall # D-148-3.

CODE
Lot #106909A, Exp 11/2003; and Lot #205752A, Exp 08/2004.

RECALLING FIRM/MANUFACTURER
Recalling Firm: Boehringer Ingelheim Roxane Laboratories, Columbus, OH,
by letter on December 9, 2002.
Manufactured: Boehringer Ingelheim Pharma KG, Ingelheim Germany. Firm
initiated recall ongoing.

REASON
Container defect: loss of integrity of the air tight seal on the blister
cards.

VOLUME OF PRODUCT IN COMMERCE
264 boxes (73 - lot 106909A; and 191- lot 205752A).

DISTRIBUTION
Nationwide.

Send mail to: Webmaster@COPD-International.com with questions
or comments about this web site.
Copyright © 2002-2004 ----- COPD-International.com
Last modified:
March 8, 2003
Disclaimer